NeoGenomics

Compliant

Under AAOIFI Standard 21, NeoGenomics is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.

TickerNEO

ExchangeNASDAQ

SectorCancer Genetic Testing

Full ratios for NeoGenomics (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding NeoGenomics or any other security.